Israel vs Republic of Korea: Amphetamine use disorder deaths by sex
Israel
1.08 deaths
in 2021
Republic of Korea
0.89 deaths
in 2021
Israel rank
59th
Republic of Korea rank
62nd
Amphetamine use disorder deaths by sex over time
- Israel
- Republic of Korea
How they compare
Israel currently reports 1.08 deaths against 0.89 deaths in Republic of Korea, a difference of 0.19 deaths.
That makes Israel's figure about 1.2 times Republic of Korea's.
The two have swapped places 10 times across 22 shared years of data; in 2000 it was Israel ahead.
Israel ranks 59th and Republic of Korea ranks 62nd of 194 countries.
Across the 3 decades both report, Israel averaged higher in 2 and Republic of Korea in 1.
Head to head by decade
| Decade | Israel | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.366 deaths | 0.24 deaths | 0.126 deaths | Israel |
| 2010s | 0.443 deaths | 0.51 deaths | 0.067 deaths | Republic of Korea |
| 2020s | 1.23 deaths | 0.69 deaths | 0.54 deaths | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder deaths by sex, Israel or Republic of Korea?
- Israel, at 1.08 deaths against 0.89 deaths in Republic of Korea as of 2021.
- What is the difference in amphetamine use disorder deaths by sex between Israel and Republic of Korea?
- 0.19 deaths, with Israel ahead.
- How many years of comparable data are there for Israel and Republic of Korea?
- 22 years are reported by both, from 2000 to 2021.
- How do Israel and Republic of Korea rank globally for amphetamine use disorder deaths by sex?
- Israel ranks 59th and Republic of Korea ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Amphetamine use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in females.